JCHAIN and neoplasm: We analysed CD14+ and JCHAIN+ spots across six samples and found that pro‐tumour pathways, including angiogenesis, extracellular matrix (ECM) receptor interaction and Vascular endothelial growth factor (VEGF) signalling, were enriched in CD14+ spots.